コンパニオン診断テクノロジーの世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Companion Diagnostic Technologies Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00228 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、コンパニオン診断テクノロジーの世界市場を広く調査・分析し、今後の市場展望をまとめております。コンパニオン診断テクノロジーの種類別市場規模（免疫組織化学、分子診断）、用途別市場規模（腫瘍学、心臓血管系、中枢神経系、自己免疫・炎症、ウイルス学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Dako (Agilent Technologies)、Resonance Health Ltd.、Abbott Laboratories、Qiagen、Myriad Genetics、Roche、Danaher、bioMerieux、Thermo Fisher Scientific、Leica Microsystems ・地域別グローバル市場分析 2015年-2020年 ・コンパニオン診断テクノロジーの北米市場（アメリカ、カナダ、メキシコ） ・コンパニオン診断テクノロジーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・コンパニオン診断テクノロジーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・コンパニオン診断テクノロジーの南米市場（ブラジル、アルゼンチン） ・コンパニオン診断テクノロジーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫組織化学、分子診断 ・用途別分析：腫瘍学、心臓血管系、中枢神経系、自己免疫・炎症、ウイルス学、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Companion Diagnostic Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 3954.1 million by 2025, from USD 2618.6 million in 2019.

The Companion Diagnostic Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Companion Diagnostic Technologies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Companion Diagnostic Technologies market has been segmented into:
Immunohistochemistry
Molecular Diagnostics

By Application, Companion Diagnostic Technologies has been segmented into:
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Diagnostic Technologies market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Diagnostic Technologies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Diagnostic Technologies market.

The report offers in-depth assessment of the growth and other aspects of the Companion Diagnostic Technologies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Companion Diagnostic Technologies Market Share Analysis
Companion Diagnostic Technologies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Diagnostic Technologies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Diagnostic Technologies sales, revenue and market share for each player covered in this report.

The major players covered in Companion Diagnostic Technologies are:
Dako (Agilent Technologies)
Resonance Health Ltd.
Abbott Laboratories
Qiagen
Myriad Genetics
Roche
Danaher
bioMerieux
Thermo Fisher Scientific
Leica Microsystems

レポート目次

---

Table of Contents

1 Companion Diagnostic Technologies Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Technologies
1.2 Classification of Companion Diagnostic Technologies by Type
1.2.1 Global Companion Diagnostic Technologies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Diagnostic Technologies Revenue Market Share by Type in 2019
1.2.3 Immunohistochemistry
1.2.4 Molecular Diagnostics
1.3 Global Companion Diagnostic Technologies Market by Application
1.3.1 Overview: Global Companion Diagnostic Technologies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Global Companion Diagnostic Technologies Market by Regions
1.4.1 Global Companion Diagnostic Technologies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Diagnostic Technologies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Diagnostic Technologies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Technologies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Technologies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Diagnostic Technologies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Technologies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Dako (Agilent Technologies)
2.1.1 Dako (Agilent Technologies) Details
2.1.2 Dako (Agilent Technologies) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Dako (Agilent Technologies) SWOT Analysis
2.1.4 Dako (Agilent Technologies) Product and Services
2.1.5 Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Resonance Health Ltd.
2.2.1 Resonance Health Ltd. Details
2.2.2 Resonance Health Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Resonance Health Ltd. SWOT Analysis
2.2.4 Resonance Health Ltd. Product and Services
2.2.5 Resonance Health Ltd. Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories SWOT Analysis
2.3.4 Abbott Laboratories Product and Services
2.3.5 Abbott Laboratories Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qiagen SWOT Analysis
2.4.4 Qiagen Product and Services
2.4.5 Qiagen Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Myriad Genetics
2.5.1 Myriad Genetics Details
2.5.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Myriad Genetics SWOT Analysis
2.5.4 Myriad Genetics Product and Services
2.5.5 Myriad Genetics Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.7 Danaher
2.7.1 Danaher Details
2.7.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Danaher SWOT Analysis
2.7.4 Danaher Product and Services
2.7.5 Danaher Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.8 bioMerieux
2.8.1 bioMerieux Details
2.8.2 bioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 bioMerieux SWOT Analysis
2.8.4 bioMerieux Product and Services
2.8.5 bioMerieux Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Thermo Fisher Scientific SWOT Analysis
2.9.4 Thermo Fisher Scientific Product and Services
2.9.5 Thermo Fisher Scientific Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.10 Leica Microsystems
2.10.1 Leica Microsystems Details
2.10.2 Leica Microsystems Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Leica Microsystems SWOT Analysis
2.10.4 Leica Microsystems Product and Services
2.10.5 Leica Microsystems Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Diagnostic Technologies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Technologies Players Market Share
3.2.2 Top 10 Companion Diagnostic Technologies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Diagnostic Technologies Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
4.5 South America Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
5 North America Companion Diagnostic Technologies Revenue by Countries
5.1 North America Companion Diagnostic Technologies Revenue by Countries (2015-2020)
5.2 USA Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
6 Europe Companion Diagnostic Technologies Revenue by Countries
6.1 Europe Companion Diagnostic Technologies Revenue by Countries (2015-2020)
6.2 Germany Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
6.3 UK Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
6.4 France Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Diagnostic Technologies Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Technologies Revenue by Countries (2015-2020)
7.2 China Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
7.5 India Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
8 South America Companion Diagnostic Technologies Revenue by Countries
8.1 South America Companion Diagnostic Technologies Revenue by Countries (2015-2020)
8.2 Brazil Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Diagnostic Technologies by Countries
9.1 Middle East & Africa Companion Diagnostic Technologies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Diagnostic Technologies Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Diagnostic Technologies Market Forecast by Type (2019-2024)
10.3 Immunohistochemistry Revenue Growth Rate (2015-2025)
10.4 Molecular Diagnostics Revenue Growth Rate (2015-2025)
11 Global Companion Diagnostic Technologies Market Segment by Application
11.1 Global Companion Diagnostic Technologies Revenue Market Share by Application (2015-2020)
11.2 Companion Diagnostic Technologies Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Cardiovascular Revenue Growth (2015-2020)
11.5 Central Nervous System Revenue Growth (2015-2020)
11.6 Auto immune & Inflammation Revenue Growth (2015-2020)
11.7 Virology Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Companion Diagnostic Technologies Market Size Forecast (2021-2025)
12.1 Global Companion Diagnostic Technologies Market Size Forecast (2021-2025)
12.2 Global Companion Diagnostic Technologies Market Forecast by Regions (2021-2025)
12.3 North America Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
12.4 Europe Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
12.6 South America Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Companion Diagnostic Technologies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Companion Diagnostic Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Companion Diagnostic Technologies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Companion Diagnostic Technologies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Dako (Agilent Technologies) Corporate Information, Location and Competitors
Table 6. Dako (Agilent Technologies) Companion Diagnostic Technologies Major Business
Table 7. Dako (Agilent Technologies) Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 8. Dako (Agilent Technologies) SWOT Analysis
Table 9. Dako (Agilent Technologies) Companion Diagnostic Technologies Product and Solutions
Table 10. Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Resonance Health Ltd. Corporate Information, Location and Competitors
Table 12. Resonance Health Ltd. Companion Diagnostic Technologies Major Business
Table 13. Resonance Health Ltd. Companion Diagnostic Technologies Total Revenue (USD Million) (2018-2019)
Table 14. Resonance Health Ltd. SWOT Analysis
Table 15. Resonance Health Ltd. Companion Diagnostic Technologies Product and Solutions
Table 16. Resonance Health Ltd. Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Laboratories Corporate Information, Location and Competitors
Table 18. Abbott Laboratories Companion Diagnostic Technologies Major Business
Table 19. Abbott Laboratories Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 20. Abbott Laboratories SWOT Analysis
Table 21. Abbott Laboratories Companion Diagnostic Technologies Product and Solutions
Table 22. Abbott Laboratories Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Qiagen Corporate Information, Location and Competitors
Table 24. Qiagen Companion Diagnostic Technologies Major Business
Table 25. Qiagen Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 26. Qiagen SWOT Analysis
Table 27. Qiagen Companion Diagnostic Technologies Product and Solutions
Table 28. Qiagen Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Myriad Genetics Corporate Information, Location and Competitors
Table 30. Myriad Genetics Companion Diagnostic Technologies Major Business
Table 31. Myriad Genetics Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 32. Myriad Genetics SWOT Analysis
Table 33. Myriad Genetics Companion Diagnostic Technologies Product and Solutions
Table 34. Myriad Genetics Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche Companion Diagnostic Technologies Major Business
Table 37. Roche Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche Companion Diagnostic Technologies Product and Solutions
Table 40. Roche Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Danaher Corporate Information, Location and Competitors
Table 42. Danaher Companion Diagnostic Technologies Major Business
Table 43. Danaher Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 44. Danaher SWOT Analysis
Table 45. Danaher Companion Diagnostic Technologies Product and Solutions
Table 46. Danaher Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. bioMerieux Corporate Information, Location and Competitors
Table 48. bioMerieux Companion Diagnostic Technologies Major Business
Table 49. bioMerieux Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 50. bioMerieux SWOT Analysis
Table 51. bioMerieux Companion Diagnostic Technologies Product and Solutions
Table 52. bioMerieux Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 54. Thermo Fisher Scientific Companion Diagnostic Technologies Major Business
Table 55. Thermo Fisher Scientific Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 56. Thermo Fisher Scientific SWOT Analysis
Table 57. Thermo Fisher Scientific Companion Diagnostic Technologies Product and Solutions
Table 58. Thermo Fisher Scientific Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Leica Microsystems Corporate Information, Location and Competitors
Table 60. Leica Microsystems Companion Diagnostic Technologies Major Business
Table 61. Leica Microsystems Companion Diagnostic Technologies Total Revenue (USD Million) (2017-2018)
Table 62. Leica Microsystems SWOT Analysis
Table 63. Leica Microsystems Companion Diagnostic Technologies Product and Solutions
Table 64. Leica Microsystems Companion Diagnostic Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Companion Diagnostic Technologies Revenue (Million USD) by Players (2015-2020)
Table 66. Global Companion Diagnostic Technologies Revenue Share by Players (2015-2020)
Table 67. Global Companion Diagnostic Technologies Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Companion Diagnostic Technologies Revenue Market Share by Regions (2015-2020)
Table 69. North America Companion Diagnostic Technologies Revenue by Countries (2015-2020)
Table 70. North America Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Table 71. Europe Companion Diagnostic Technologies Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Companion Diagnostic Technologies Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Companion Diagnostic Technologies Revenue by Countries (2015-2020)
Table 74. South America Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Companion Diagnostic Technologies Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Table 77. Global Companion Diagnostic Technologies Revenue (Million USD) by Type (2015-2020)
Table 78. Global Companion Diagnostic Technologies Revenue Share by Type (2015-2020)
Table 79. Global Companion Diagnostic Technologies Revenue Forecast by Type (2021-2025)
Table 80. Global Companion Diagnostic Technologies Revenue by Application (2015-2020)
Table 81. Global Companion Diagnostic Technologies Revenue Share by Application (2015-2020)
Table 82. Global Companion Diagnostic Technologies Revenue Forecast by Application (2021-2025)
Table 83. Global Companion Diagnostic Technologies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Companion Diagnostic Technologies Picture
Figure 2. Global Companion Diagnostic Technologies Revenue Market Share by Type in 2019
Figure 3. Immunohistochemistry Picture
Figure 4. Molecular Diagnostics Picture
Figure 5. Companion Diagnostic Technologies Revenue Market Share by Application in 2019
Figure 6. Oncology Picture
Figure 7. Cardiovascular Picture
Figure 8. Central Nervous System Picture
Figure 9. Auto immune & Inflammation Picture
Figure 10. Virology Picture
Figure 11. Others Picture
Figure 12. Global Companion Diagnostic Technologies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Companion Diagnostic Technologies Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Companion Diagnostic Technologies Revenue Market Share in 2019
Figure 21. Global Top 10 Players Companion Diagnostic Technologies Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Companion Diagnostic Technologies Revenue Market Share by Regions (2015-2020)
Figure 25. Global Companion Diagnostic Technologies Revenue Market Share by Regions in 2018
Figure 26. North America Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 27. Europe Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 29. South America Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 31. North America Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Figure 32. North America Companion Diagnostic Technologies Revenue Market Share by Countries in 2019
Figure 33. USA Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 34. Canada Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 36. Europe Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Companion Diagnostic Technologies Revenue Market Share by Countries in 2019
Figure 38. Germany Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 39. UK Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 40. France Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 41. Russia Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 42. Italy Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Companion Diagnostic Technologies Revenue Market Share by Countries in 2019
Figure 45. China Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 46. Japan Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 47. Korea Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 48. India Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 50. South America Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Figure 51. South America Companion Diagnostic Technologies Revenue Market Share by Countries in 2019
Figure 52. Brazil Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Companion Diagnostic Technologies Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Companion Diagnostic Technologies Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 57. UAE Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Companion Diagnostic Technologies Revenue and Growth Rate (2015-2020)
Figure 60. Global Companion Diagnostic Technologies Revenue Share by Type (2015-2020)
Figure 61. Global Companion Diagnostic Technologies Revenue Share by Type in 2019
Figure 62. Global Companion Diagnostic Technologies Market Share Forecast by Type (2021-2025)
Figure 63. Global Immunohistochemistry Revenue Growth Rate (2015-2020)
Figure 64. Global Molecular Diagnostics Revenue Growth Rate (2015-2020)
Figure 65. Global Companion Diagnostic Technologies Revenue Share by Application (2015-2020)
Figure 66. Global Companion Diagnostic Technologies Revenue Share by Application in 2019
Figure 67. Global Companion Diagnostic Technologies Market Share Forecast by Application (2021-2025)
Figure 68. Global Oncology Revenue Growth Rate (2015-2020)
Figure 69. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 70. Global Central Nervous System Revenue Growth Rate (2015-2020)
Figure 71. Global Auto immune & Inflammation Revenue Growth Rate (2015-2020)
Figure 72. Global Virology Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Companion Diagnostic Technologies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Companion Diagnostic Technologies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Companion Diagnostic Technologies Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
Figure 78. Europe Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
Figure 80. South America Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Companion Diagnostic Technologies Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---